AVXL logo

Anavex Life Sciences (AVXL) Net Income

Annual Net Income

-$43.00 M
+$4.50 M+9.48%

September 30, 2024

Summary

Performance

1-Year Change

+9.48%

3-Year Change

-13.43%

5-Year Change

-63.54%

15-Year Change

-219.47%

AVXL Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.16%
AVXL annual net profit is higher than 40.16% of companies in Healthcare sector

High & Low

All-time High

-$14.40 K

3-Year Low

-$47.98 M

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
AVXL previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
AVXL next annual earnings announcement has not yet been scheduled

OtherAVXLprofitabilitymetrics:

Annual Net Margin

-
AVXL annual net profit margin value is unknown

Annual Revenue

-
AVXL annual revenue value is unknown

Annual Gross Profit

-
AVXL annual gross profit value is unknown

Annual EPS

-$0.52
AVXL annual earnings per share is -$0.52

Quarterly Net Income

-$11.62 M
+$594.00 K+4.86%

September 30, 2024

Summary

Performance

3-Month Change

+4.86%

1-Year Change

+4.86%

3-Year Change

+0.84%

5-Year Change

+0.84%

AVXL Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.34%
AVXL quarterly net profit is higher than 37.34% of companies in Healthcare sector

High & Low

All-time High

$358.60 K
AVXL quarterly net profit is currently -3340.38% below its historical high of $358.60 thousand

3-Year Low

-$14.29 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AVXL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
AVXL next earnings announcement is scheduled for Feb 7, 2025

OtherAVXLprofitabilitymetrics:

Quarterly Net Margin

-
AVXL quarterly net profit margin value is unknown

Quarterly Revenue

-
AVXL quarterly revenue value is unknown

Quarterly Gross Profit

-
AVXL quarterly gross profit value is unknown

Quarterly EPS

-$0.14
AVXL quarterly earnings per share is -$0.14

TTM Net Income

-$43.00 M
-$1.47 M-3.55%

September 30, 2024

Summary

Performance

3-Month Change

-3.55%

1-Year Change

-3.55%

3-Year Change

-13.43%

5-Year Change

-13.43%

AVXL TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.05%
AVXL TTM net profit is higher than 40.05% of companies in Healthcare sector

High & Low

All-time High

-$3900.00

3-Year Low

-$52.74 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AVXL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
AVXL next earnings announcement is scheduled for Feb 7, 2025

OtherAVXLprofitabilitymetrics:

Annual Net Margin

-
AVXL annual net profit margin value is unknown

TTM Revenue

-
AVXL TTM revenue value is unknown

TTM Gross Profit

-
AVXL TTM gross profit value is unknown

TTM EPS

-$0.52
AVXL TTM earnings per share is -$0.52

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$43.00 M
AVXL annual net profit is -$43.00 million

Annual Revenue

-
AVXL annual revenue value is unknown

Annual Cost Of Goods Sold

-
AVXL annual cost of goods sold value is unknown

Annual Operating Expenses

$52.80 M
AVXL annual total operating expenses is $52.80 million

Annual Interest Expense

$0.00
AVXL annual interest expense is $0.00

Annual Income Tax

$0.00
AVXL annual income tax is $0.00

AVXL Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.5%+4.9%-3.5%
3 y3 years-13.4%+0.8%-13.4%
5 y5 years-63.5%+0.8%-13.4%

AVXL Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.4%+10.4%-34.8%+18.7%-5.9%+18.5%
5 y5-year-63.6%+10.4%-94.8%+18.7%-65.9%+18.5%
alltimeall time<-9999.0%+10.4%-3340.4%+18.7%<-9999.0%+18.5%

Anavex Life Sciences Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-$43.00 M(-9.5%)
-$11.62 M(-4.9%)
-$43.00 M(+3.5%)
Jun 2024
-
-$12.21 M(+15.8%)
-$41.53 M(+2.3%)
Mar 2024
-
-$10.55 M(+22.3%)
-$40.59 M(-5.9%)
Dec 2023
-
-$8.62 M(-15.0%)
-$43.16 M(-9.2%)
Sep 2023
-$47.51 M(-1.0%)
-$10.15 M(-10.1%)
-$47.51 M(-8.0%)
Jun 2023
-
-$11.28 M(-13.9%)
-$51.65 M(-2.1%)
Mar 2023
-
-$13.11 M(+1.0%)
-$52.74 M(+5.3%)
Dec 2022
-
-$12.97 M(-9.2%)
-$50.07 M(+4.4%)
Sep 2022
-$47.98 M(+26.6%)
-$14.29 M(+15.6%)
-$47.98 M(+5.7%)
Jun 2022
-
-$12.37 M(+18.5%)
-$45.41 M(+5.1%)
Mar 2022
-
-$10.44 M(-4.1%)
-$43.22 M(+5.6%)
Dec 2021
-
-$10.88 M(-7.1%)
-$40.94 M(+8.0%)
Sep 2021
-$37.91 M(+44.2%)
-$11.72 M(+15.1%)
-$37.91 M(+17.9%)
Jun 2021
-
-$10.18 M(+24.8%)
-$32.16 M(+13.0%)
Mar 2021
-
-$8.16 M(+3.8%)
-$28.46 M(+3.3%)
Dec 2020
-
-$7.86 M(+31.7%)
-$27.54 M(+4.8%)
Sep 2020
-$26.28 M(-0.1%)
-$5.97 M(-8.0%)
-$26.28 M(+1.4%)
Jun 2020
-
-$6.49 M(-10.4%)
-$25.92 M(-0.1%)
Mar 2020
-
-$7.24 M(+9.8%)
-$25.96 M(-0.0%)
Dec 2019
-
-$6.59 M(+17.6%)
-$25.97 M(-1.2%)
Sep 2019
-$26.30 M(+52.4%)
-$5.61 M(-14.0%)
-$26.29 M(+0.1%)
Jun 2019
-
-$6.52 M(-10.0%)
-$26.28 M(+16.2%)
Mar 2019
-
-$7.25 M(+4.7%)
-$22.61 M(+12.4%)
Dec 2018
-
-$6.92 M(+23.7%)
-$20.11 M(+16.6%)
Sep 2018
-$17.25 M(+28.2%)
-$5.59 M(+96.3%)
-$17.25 M(+2.6%)
Jun 2018
-
-$2.85 M(-40.0%)
-$16.82 M(-4.3%)
Mar 2018
-
-$4.75 M(+17.1%)
-$17.58 M(+22.3%)
Dec 2017
-
-$4.06 M(-21.3%)
-$14.37 M(+6.8%)
Sep 2017
-$13.46 M(-8.7%)
-$5.15 M(+42.8%)
-$13.46 M(-9.2%)
Jun 2017
-
-$3.61 M(+133.0%)
-$14.82 M(+10.2%)
Mar 2017
-
-$1.55 M(-50.8%)
-$13.45 M(-3.5%)
Dec 2016
-
-$3.15 M(-51.7%)
-$13.93 M(-5.5%)
Sep 2016
-$14.74 M(+21.7%)
-$6.51 M(+190.6%)
-$14.74 M(+8.5%)
Jun 2016
-
-$2.24 M(+10.3%)
-$13.58 M(-12.8%)
Mar 2016
-
-$2.03 M(-48.6%)
-$15.58 M(+2.0%)
Dec 2015
-
-$3.95 M(-26.2%)
-$15.28 M(+26.2%)
Sep 2015
-$12.11 M(+21.5%)
-$5.36 M(+26.3%)
-$12.11 M(-19.6%)
Jun 2015
-
-$4.24 M(+145.8%)
-$15.05 M(+27.3%)
Mar 2015
-
-$1.72 M(+119.3%)
-$11.82 M(+6.4%)
Dec 2014
-
-$786.70 K(-90.5%)
-$11.11 M(+11.5%)
DateAnnualQuarterlyTTM
Sep 2014
-$9.97 M(+169.4%)
-$8.30 M(+722.4%)
-$9.97 M(+114.0%)
Jun 2014
-
-$1.01 M(-1.0%)
-$4.66 M(+22.6%)
Mar 2014
-
-$1.02 M(-384.1%)
-$3.80 M(+31.6%)
Dec 2013
-
$358.60 K(-112.0%)
-$2.89 M(-21.9%)
Sep 2013
-$3.70 M(-55.4%)
-$2.99 M(+1867.4%)
-$3.70 M(+166.4%)
Jun 2013
-
-$151.90 K(+43.2%)
-$1.39 M(-76.0%)
Mar 2013
-
-$106.10 K(-76.6%)
-$5.78 M(-12.2%)
Dec 2012
-
-$453.50 K(-33.1%)
-$6.58 M(-20.7%)
Sep 2012
-$8.30 M(+13.6%)
-$677.40 K(-85.1%)
-$8.30 M(-8.2%)
Jun 2012
-
-$4.54 M(+399.1%)
-$9.05 M(+48.7%)
Mar 2012
-
-$910.20 K(-58.1%)
-$6.09 M(-14.9%)
Dec 2011
-
-$2.17 M(+53.0%)
-$7.15 M(+4.2%)
Sep 2011
-$7.31 M(-16.8%)
-$1.42 M(-10.0%)
-$6.86 M(-16.6%)
Jun 2011
-
-$1.58 M(-20.0%)
-$8.23 M(-4.5%)
Mar 2011
-
-$1.97 M(+4.5%)
-$8.62 M(+3.1%)
Dec 2010
-
-$1.89 M(-32.4%)
-$8.36 M(+20.5%)
Sep 2010
-$8.78 M(+59.7%)
-$2.79 M(+42.0%)
-$6.94 M(+13.0%)
Jun 2010
-
-$1.97 M(+14.7%)
-$6.14 M(+11.4%)
Mar 2010
-
-$1.71 M(+266.6%)
-$5.51 M(+9.4%)
Dec 2009
-
-$467.60 K(-76.5%)
-$5.04 M(-8.4%)
Sep 2009
-$5.50 M(+2.8%)
-$1.99 M(+48.6%)
-$5.50 M(-1.5%)
Jun 2009
-
-$1.34 M(+7.9%)
-$5.58 M(-5.8%)
Mar 2009
-
-$1.24 M(+33.8%)
-$5.92 M(+10.4%)
Dec 2008
-
-$928.00 K(-55.2%)
-$5.36 M(-1.1%)
Sep 2008
-$5.35 M(+238.7%)
-$2.07 M(+23.3%)
-$5.42 M(+20.6%)
Jun 2008
-
-$1.68 M(+146.4%)
-$4.50 M(+46.4%)
Mar 2008
-
-$682.00 K(-31.1%)
-$3.07 M(+20.1%)
Dec 2007
-
-$989.30 K(-13.5%)
-$2.56 M(+61.8%)
Sep 2007
-$1.58 M(+6096.1%)
-$1.14 M(+348.9%)
-$1.58 M(+257.4%)
Jun 2007
-
-$254.80 K(+50.7%)
-$442.00 K(+129.1%)
Mar 2007
-
-$169.10 K(+1274.8%)
-$192.90 K(+576.8%)
Dec 2006
-
-$12.30 K(+112.1%)
-$28.50 K(+11.3%)
Sep 2006
-$25.50 K(-72.2%)
-$5800.00(+1.8%)
-$25.60 K(-58.6%)
Jun 2006
-
-$5700.00(+21.3%)
-$61.80 K(-39.3%)
Mar 2006
-
-$4700.00(-50.0%)
-$101.80 K(-28.7%)
Dec 2005
-
-$9400.00(-77.6%)
-$142.80 K(+4.0%)
Sep 2005
-$91.60 K(+536.1%)
-$42.00 K(-8.1%)
-$137.30 K(+44.1%)
Jun 2005
-
-$45.70 K(0.0%)
-$95.30 K(+92.1%)
Mar 2005
-
-$45.70 K(+1071.8%)
-$49.60 K(+1171.8%)
Dec 2004
-
-$3900.00
-$3900.00
Sep 2004
-$14.40 K
-
-

FAQ

  • What is Anavex Life Sciences annual net profit?
  • What is the all time high annual net income for Anavex Life Sciences?
  • What is Anavex Life Sciences annual net income year-on-year change?
  • What is Anavex Life Sciences quarterly net profit?
  • What is the all time high quarterly net income for Anavex Life Sciences?
  • What is Anavex Life Sciences quarterly net income year-on-year change?
  • What is Anavex Life Sciences TTM net profit?
  • What is the all time high TTM net income for Anavex Life Sciences?
  • What is Anavex Life Sciences TTM net income year-on-year change?

What is Anavex Life Sciences annual net profit?

The current annual net income of AVXL is -$43.00 M

What is the all time high annual net income for Anavex Life Sciences?

Anavex Life Sciences all-time high annual net profit is -$14.40 K

What is Anavex Life Sciences annual net income year-on-year change?

Over the past year, AVXL annual net profit has changed by +$4.50 M (+9.48%)

What is Anavex Life Sciences quarterly net profit?

The current quarterly net income of AVXL is -$11.62 M

What is the all time high quarterly net income for Anavex Life Sciences?

Anavex Life Sciences all-time high quarterly net profit is $358.60 K

What is Anavex Life Sciences quarterly net income year-on-year change?

Over the past year, AVXL quarterly net profit has changed by +$594.00 K (+4.86%)

What is Anavex Life Sciences TTM net profit?

The current TTM net income of AVXL is -$43.00 M

What is the all time high TTM net income for Anavex Life Sciences?

Anavex Life Sciences all-time high TTM net profit is -$3900.00

What is Anavex Life Sciences TTM net income year-on-year change?

Over the past year, AVXL TTM net profit has changed by -$1.47 M (-3.55%)